| Download the amazing global Makindo app: Android | Apple | |
|---|---|
| MEDICAL DISCLAIMER: Educational use only. Not for diagnosis or management. See below for full disclaimer. |
Tinzaparin (Innohep)💊
📖 About
Always check the BNF link here.
- 💉 Tinzaparin – a Low Molecular Weight Heparin (LMWH).
- 🎯 More predictable anticoagulant effect than unfractionated heparin (UFH).
⚡ Mechanism of Action
- 🔗 Binds to antithrombin → accelerates inactivation of Factor Xa.
- ⬇️ Reduces thrombin generation and clot formation.
- 📊 Predictable dose–response allows once-daily dosing without routine monitoring (except in special groups).
🩺 Indications & Dosing (verify in BNF/datasheet)
| Indication | Details |
|---|---|
| 🛡️ DVT/PE Prophylaxis |
Tinzaparin
• 50 IU/kg SC OD • Or fixed dose 3,500–4,500 IU SC OD |
| 💉 DVT/PE Treatment |
Tinzaparin
• 175 IU/kg SC OD • Given with warfarin until INR therapeutic 📌 Example: 66–70 kg → 12,000 IU (0.6 mL) once daily |
| 🎗️ DVT/PE in Active Cancer |
Tinzaparin
• 175 IU/kg SC OD • Continue ≥6 months (specialist follow-up) |
⚠️ Interactions
- See LMWH section – ↑ bleeding risk with other anticoagulants, antiplatelets, fibrinolytics.
⚠️ Cautions
- ⬇️ Reduce dose in renal failure.
- 📊 Monitor anti-Factor Xa in: renal impairment, pregnancy, liver failure, or extremes of body weight.
- 🩸 Increased bleeding risk with invasive procedures or trauma.
🚫 Contraindications
- Same as other LMWHs (see general LMWH guidance).
- ❌ Severe renal failure (CrCl <30 mL/min).
- Active major bleeding or history of HIT.
💥 Side Effects
- 🩸 Bleeding (dose-related).
- ⬇️ Thrombocytopenia (HIT risk – usually 5–10 days after start).
- ⬆️ Raised AST/ALT (transient).
- 🦴 Long-term use: osteoporosis (rare, with extended therapy).
📑 References
| The content on this website is provided for educational and informational purposes only to support exam preparation (e.g., MLA, MRCP, USMLE) and learning. This is NOT medical advice, diagnosis, treatment, or professional guidance. It does not replace consultation with a qualified healthcare professional, official guidelines (e.g., NICE, GMC, BNF), or supervised clinical practice. Always verify information with current, authoritative sources. Makindo and its contributors accept no liability for any reliance on this content, including errors, omissions, or any resulting harm, loss, or consequences. By using this site, you agree to these terms. |
|
|
Categories
- A Level
- About
- Acute Medicine
- Anaesthetics and Critical Care
- Anatomy
- Anatomy and Physiology
- Biochemistry
- Book
- Cardiology
- Collections
- CompSci
- Crib Sheets
- Dental
- Dermatology
- Differentials
- Drugs
- ENT
- Education
- Electrocardiogram
- Embryology
- Emergency Medicine
- Endocrinology
- Ethics
- Foundation Doctors
- GCSE
- Gastroenterology
- General Practice
- Genetics
- Geriatric Medicine
- Guidelines
- Gynaecology
- Haematology
- Hepatology
- Immunology
- Infectious Diseases
- Infographic
- Investigations
- Lists
- Mandatory Training
- Medical Students
- Microbiology
- Nephrology
- Neu
- Neurology
- Neurosurgery
- Nutrition
- OSCE
- OSCEs
- Obstetrics
- Obstetrics Gynaecology
- Oncology
- Ophthalmology
- Oral Medicine and Dentistry
- Orthopaedics
- Paediatrics
- Palliative
- Pathology
- Pharmacology
- Physiology
- Procedures
- Psychiatry
- Public Health
- Radiology
- Renal
- Respiratory
- Resuscitation
- Revision
- Rheumatology
- Statistics and Research
- Stroke
- Surgery
- Toxicology
- Trauma and Orthopaedics
- USMLE
- Urology
- Vascular Surgery